The gamma isoform of the peroxisome proliferator-activated receptor, PPAR g
amma, regulates adipocyte differentiation and has recently been shown to be
expressed in neoplasia of the colon and other tissues. We have found four
somatic PPAR gamma mutations among 55 sporadic coln cancers: one nonsense,
one frameshift, and two missense mutations. Each greatly impaired the funct
ion of the protein. c.472delA results in deletion of the entire ligand bind
ing domain. Q286P and K319X retain a total or partial ligand binding domain
but lose the ability to activate transcription through a failure to bind t
o ligands. R288H showed a normal response to synthetic ligands but greatly
decreased transcription and binding when exposed to natural ligands. These
data indicate that colon cancer in humans is associated with loss-of-functi
on mutations in PPAR gamma.